ALMA DIAZ: Open Payments
NPI 1225636848 · GREENSBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,659 in 65 payments from 19 companies in 2025. Trend: 2023 $570 · 2024 $1,498 · 2025 $1,659
Food & beverage: $1,659
| Company | Payments | Amount |
|---|---|---|
| Alnylam Pharmaceuticals Inc. | 5 | $209 |
| AstraZeneca Pharmaceuticals LP | 11 | $198 |
| ABIOMED | 3 | $194 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 8 | $166 |
| Abbott Laboratories | 1 | $150 |
| Merck Sharp & Dohme LLC | 8 | $144 |
| United Therapeutics Corporation | 4 | $86 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $74 |
| CVRx, Inc. | 3 | $71 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $70 |
Products named: LifeVest, TRICLIP, AMVUTTRA, FARXIGA, VERQUVO, WAINUA, Tyvaso, JARDIANCE.
Industry payments across NC — which companies pay providers there.
